Current Clinical Trial for Mesothelioma Patients: Bortezomib

Read about a current clinical trial being conducted to study the effects of Bortezomib for patients who have been diagnosed with mesothelioma. Please note: this information is provided by Weitz & Luxenberg for informational purposes only. At this time, the clinical trials are not being conducted in the United States.

Bortezomib in Treating Patients With Malignant Pleural Mesothelioma

Rational and Purpose

Bortezomib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. This phase II trial is studying the side effects of Bortezomib and how well it works in treating patients with malignant pleural mesothelioma.

Study Description
Phase, Type and Design: Phase II Interventional study; Treatment, Non-Randomized, Open Label; An Open Label Phase II Multicentre Clinical Trial of Single Agent Bortezomib in Patients With Malignant Pleural Mesothelioma

Courtesy of ClinicalTrials.gov,

Other helpful links:

Asbestos Asbestos
Asbestos and lung cancer Asbestos and lung cancer
Mesothelioma attorney Mesothelioma attorney
Mesothelioma Lawyer Mesothelioma lawyer
Asbestos attorney Asbestos attorney